Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Imax Corp has a consensus price target of $38.31 based on the ratings of 13 analysts. The high is $47 issued by Wells Fargo on December 18, 2025. The low is $23 issued by Seaport Global on July 24, 2024. The 3 most-recent analyst ratings were released by Macquarie, Wells Fargo, and JP Morgan on January 15, 2026, December 18, 2025, and December 15, 2025, respectively. With an average price target of $46 between Macquarie, Wells Fargo, and JP Morgan, there's an implied 32.91% upside for Imax Corp from these most-recent analyst ratings.
1calculated from analyst ratings
| Buy Now | Get Alert | ||||||
|---|---|---|---|---|---|---|---|
| 01/15/2026 | Buy Now | 27.13% | Macquarie | $39 → $44 | Maintains | Outperform | Get Alert |
| 12/18/2025 | Buy Now | 35.8% | Wells Fargo | $40 → $47 | Maintains | Overweight | Get Alert |
| 12/15/2025 | Buy Now | 35.8% | JP Morgan | $32 → $47 | Upgrade | Neutral → Overweight | Get Alert |
| 12/08/2025 | Buy Now | 32.91% | Wedbush | $39 → $46 | Maintains | Outperform | Get Alert |
| 12/08/2025 | Buy Now | 21.35% | Benchmark | $40 → $42 | Maintains | Buy | Get Alert |
| 12/08/2025 | Buy Now | 21.35% | Barrington Research | $37 → $42 | Maintains | Outperform | Get Alert |
| 12/08/2025 | Buy Now | 35.8% | Rosenblatt | $42 → $47 | Maintains | Buy | Get Alert |
| 11/25/2025 | Buy Now | -1.76% | Goldman Sachs | $22 → $34 | Upgrade | Sell → Neutral | Get Alert |
| 10/24/2025 | Buy Now | 6.91% | Barrington Research | $37 → $37 | Maintains | Outperform | Get Alert |
| 10/24/2025 | Buy Now | 15.57% | Wells Fargo | $34 → $40 | Maintains | Overweight | Get Alert |
| 10/24/2025 | Buy Now | -7.54% | JP Morgan | $31 → $32 | Maintains | Neutral | Get Alert |
| 10/24/2025 | Buy Now | 21.35% | Rosenblatt | $42 → $42 | Maintains | Buy | Get Alert |
| 10/23/2025 | Buy Now | 6.91% | Barrington Research | $37 → $37 | Maintains | Outperform | Get Alert |
| 10/14/2025 | Buy Now | 15.57% | Roth Capital | $36 → $40 | Maintains | Buy | Get Alert |
| 10/09/2025 | Buy Now | 21.35% | Rosenblatt | $37 → $42 | Maintains | Buy | Get Alert |
| 10/09/2025 | Buy Now | -10.43% | JP Morgan | $28 → $31 | Maintains | Neutral | Get Alert |
| 09/23/2025 | Buy Now | 6.91% | Barrington Research | $37 → $37 | Maintains | Outperform | Get Alert |
| 09/22/2025 | Buy Now | 12.68% | Wedbush | $35 → $39 | Maintains | Outperform | Get Alert |
| 09/19/2025 | Buy Now | 6.91% | Barrington Research | $32 → $37 | Maintains | Outperform | Get Alert |
| 07/25/2025 | Buy Now | -1.76% | Wells Fargo | $30 → $34 | Maintains | Overweight | Get Alert |
| 07/25/2025 | Buy Now | 1.13% | Wedbush | $34 → $35 | Maintains | Outperform | Get Alert |
| 07/25/2025 | Buy Now | -7.54% | Benchmark | $30 → $32 | Maintains | Buy | Get Alert |
| 07/25/2025 | Buy Now | 6.91% | Rosenblatt | $35 → $37 | Maintains | Buy | Get Alert |
| 07/24/2025 | Buy Now | -7.54% | Barrington Research | $32 → $32 | Maintains | Outperform | Get Alert |
| 07/11/2025 | Buy Now | 1.13% | Rosenblatt | $35 → $35 | Maintains | Buy | Get Alert |
| 07/09/2025 | Buy Now | 4.02% | Roth Capital | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
| 06/16/2025 | Buy Now | 1.13% | Rosenblatt | $35 → $35 | Maintains | Buy | Get Alert |
| 06/13/2025 | Buy Now | 4.02% | Roth Capital | $32 → $36 | Maintains | Buy | Get Alert |
| 04/25/2025 | Buy Now | -7.54% | Macquarie | $30 → $32 | Maintains | Outperform | Get Alert |
| 04/24/2025 | Buy Now | -7.54% | Barrington Research | $32 → $32 | Maintains | Outperform | Get Alert |
| 04/24/2025 | Buy Now | -13.32% | Wells Fargo | $32 → $30 | Maintains | Overweight | Get Alert |
| 04/24/2025 | Buy Now | 1.13% | Rosenblatt | $35 → $35 | Maintains | Buy | Get Alert |
| 04/11/2025 | Buy Now | -24.88% | JP Morgan | $27 → $26 | Maintains | Neutral | Get Alert |
| 04/10/2025 | Buy Now | -13.32% | Benchmark | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 04/10/2025 | Buy Now | 1.13% | Rosenblatt | $35 → $35 | Maintains | Buy | Get Alert |
| 02/21/2025 | Buy Now | -21.99% | JP Morgan | $25 → $27 | Maintains | Neutral | Get Alert |
| 02/20/2025 | Buy Now | -13.32% | Macquarie | $28 → $30 | Maintains | Outperform | Get Alert |
| 02/20/2025 | Buy Now | -7.54% | Barrington Research | $30 → $32 | Maintains | Outperform | Get Alert |
| 02/20/2025 | Buy Now | -13.32% | Benchmark | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 02/20/2025 | Buy Now | -7.54% | Wells Fargo | $26 → $32 | Maintains | Overweight | Get Alert |
| 02/20/2025 | Buy Now | 1.13% | Rosenblatt | $28 → $35 | Maintains | Buy | Get Alert |
| 02/12/2025 | Buy Now | -7.54% | Wedbush | $32 → $32 | Reiterates | Outperform → Outperform | Get Alert |
| 01/30/2025 | Buy Now | -27.77% | JP Morgan | $21 → $25 | Maintains | Neutral | Get Alert |
| 01/17/2025 | Buy Now | -13.32% | Benchmark | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 01/16/2025 | Buy Now | -19.1% | Rosenblatt | $28 → $28 | Maintains | Buy | Get Alert |
| 01/13/2025 | Buy Now | -13.32% | Benchmark | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 01/10/2025 | Buy Now | -13.32% | Barrington Research | $30 → $30 | Maintains | Outperform | Get Alert |
| 01/10/2025 | Buy Now | -13.32% | Benchmark | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 12/13/2024 | Buy Now | -13.32% | Benchmark | $27 → $30 | Maintains | Buy | Get Alert |
| 11/27/2024 | Buy Now | -7.54% | Wedbush | $26 → $32 | Maintains | Outperform | Get Alert |
| 11/01/2024 | Buy Now | -21.99% | Macquarie | $26 → $27 | Maintains | Outperform | Get Alert |
| 11/01/2024 | Buy Now | -19.1% | Barrington Research | $24 → $28 | Maintains | Outperform | Get Alert |
| 10/31/2024 | Buy Now | -19.1% | Roth MKM | $27 → $28 | Maintains | Buy | Get Alert |
| 10/31/2024 | Buy Now | -30.66% | Barrington Research | $24 → $24 | Maintains | Outperform | Get Alert |
| 10/31/2024 | Buy Now | -19.1% | Rosenblatt | $28 → $28 | Maintains | Buy | Get Alert |
| 10/14/2024 | Buy Now | -39.32% | JP Morgan | $20 → $21 | Maintains | Neutral | Get Alert |
| 10/10/2024 | Buy Now | -21.99% | Roth MKM | $27 → $27 | Maintains | Buy | Get Alert |
| 10/04/2024 | Buy Now | -19.1% | Rosenblatt | $28 → $28 | Maintains | Buy | Get Alert |
| 09/25/2024 | Buy Now | -30.66% | Barrington Research | $24 → $24 | Maintains | Outperform | Get Alert |
| 09/03/2024 | Buy Now | -24.88% | Wedbush | $24 → $26 | Maintains | Outperform | Get Alert |
| 07/26/2024 | Buy Now | -21.99% | Roth MKM | $23 → $27 | Maintains | Buy | Get Alert |
| 07/26/2024 | Buy Now | -19.1% | Rosenblatt | $25 → $28 | Maintains | Buy | Get Alert |
| 07/26/2024 | Buy Now | -30.66% | Wedbush | $22 → $24 | Maintains | Outperform | Get Alert |
| 07/26/2024 | Buy Now | -27.77% | Barrington Research | $25 → $25 | Maintains | Outperform | Get Alert |
| 07/26/2024 | Buy Now | -24.88% | Macquarie | $24 → $26 | Maintains | Outperform | Get Alert |
| 07/24/2024 | Buy Now | -33.55% | Seaport Global | → $23 | Initiates | → Buy | Get Alert |
| 07/18/2024 | Buy Now | -36.43% | Wedbush | $22 → $22 | Reiterates | Outperform → Outperform | Get Alert |
| 07/18/2024 | Buy Now | -33.55% | Roth MKM | $22 → $23 | Maintains | Buy | Get Alert |
| 07/08/2024 | Buy Now | -13.32% | B. Riley Securities | $27 → $30 | Maintains | Buy | Get Alert |
| 06/20/2024 | Buy Now | -36.43% | Benchmark | $22 → $22 | Reiterates | Buy → Buy | Get Alert |
| 06/17/2024 | Buy Now | -27.77% | Rosenblatt | $25 → $25 | Maintains | Buy | Get Alert |
| 04/26/2024 | Buy Now | -36.43% | Benchmark | $22 → $22 | Reiterates | Buy → Buy | Get Alert |
| 04/26/2024 | Buy Now | -36.43% | Wedbush | $22 → $22 | Reiterates | Outperform → Outperform | Get Alert |
| 04/25/2024 | Buy Now | -30.66% | Barrington Research | $24 → $24 | Maintains | Outperform | Get Alert |
| 04/22/2024 | Buy Now | -30.66% | Barrington Research | $24 → $24 | Maintains | Outperform | Get Alert |
| 04/18/2024 | Buy Now | -36.43% | Wedbush | $22 → $22 | Reiterates | Outperform → Outperform | Get Alert |
| 04/16/2024 | Buy Now | -36.43% | Benchmark | $22 → $22 | Reiterates | Buy → Buy | Get Alert |
| 04/10/2024 | Buy Now | -36.43% | Wedbush | $22 → $22 | Reiterates | Outperform → Outperform | Get Alert |
| 04/10/2024 | Buy Now | -36.43% | Benchmark | $22 → $22 | Reiterates | Buy → Buy | Get Alert |
| 03/04/2024 | Buy Now | -36.43% | Wedbush | $22 → $22 | Reiterates | Outperform → Outperform | Get Alert |
| 03/04/2024 | Buy Now | -30.66% | Barrington Research | → $24 | Reiterates | Outperform → Outperform | Get Alert |
| 02/28/2024 | Buy Now | -36.43% | Wedbush | $22 → $22 | Reiterates | Outperform → Outperform | Get Alert |
| 02/28/2024 | Buy Now | -30.66% | Barrington Research | → $24 | Reiterates | Outperform → Outperform | Get Alert |
| 02/23/2024 | Buy Now | -36.43% | Wedbush | $22 → $22 | Reiterates | Outperform → Outperform | Get Alert |
| 02/13/2024 | Buy Now | -27.77% | Rosenblatt | $30 → $25 | Maintains | Buy | Get Alert |
| 02/06/2024 | Buy Now | -50.88% | JP Morgan | $20 → $17 | Maintains | Neutral | Get Alert |
| 01/18/2024 | Buy Now | -36.43% | Benchmark | $24 → $22 | Maintains | Buy | Get Alert |
| 01/11/2024 | Buy Now | -62.44% | Goldman Sachs | $15 → $13 | Maintains | Sell | Get Alert |
| 01/02/2024 | Buy Now | -39.32% | B. Riley Securities | $27 → $21 | Maintains | Buy | Get Alert |
| 12/05/2023 | Buy Now | -13.32% | Rosenblatt | → $30 | Reiterates | Buy → Buy | Get Alert |
| 10/10/2023 | Buy Now | -13.32% | Rosenblatt | → $30 | Reiterates | Buy → Buy | Get Alert |
| 10/09/2023 | Buy Now | -30.66% | Benchmark | $23 → $24 | Maintains | Buy | Get Alert |
| 08/25/2023 | Buy Now | -13.32% | Rosenblatt | $27 → $30 | Maintains | Buy | Get Alert |
| 08/18/2023 | Buy Now | -13.32% | Rosenblatt | $27 → $30 | Maintains | Buy | Get Alert |
| 07/28/2023 | Buy Now | -30.66% | Barrington Research | → $24 | Reiterates | Outperform → Outperform | Get Alert |
| 07/27/2023 | Buy Now | -24.88% | Wedbush | → $26 | Reiterates | Outperform → Outperform | Get Alert |
| 07/27/2023 | Buy Now | -13.32% | Rosenblatt | $27 → $30 | Maintains | Buy | Get Alert |
| 07/20/2023 | Buy Now | -24.88% | Wedbush | → $26 | Reiterates | Outperform → Outperform | Get Alert |
| 07/13/2023 | Buy Now | -33.55% | Benchmark | → $23 | Reiterates | Buy → Buy | Get Alert |
| 07/13/2023 | Buy Now | -24.88% | Wedbush | → $26 | Reiterates | Outperform → Outperform | Get Alert |
The latest price target for Imax (NYSE:IMAX) was reported by Macquarie on January 15, 2026. The analyst firm set a price target for $44.00 expecting IMAX to rise to within 12 months (a possible 27.13% upside). 43 analyst firms have reported ratings in the last year.
The latest analyst rating for Imax (NYSE:IMAX) was provided by Macquarie, and Imax maintained their outperform rating.
The last upgrade for Imax Corp happened on December 15, 2025 when JP Morgan raised their price target to $47. JP Morgan previously had a neutral for Imax Corp.
There is no last downgrade for Imax.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Imax, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Imax was filed on January 15, 2026 so you should expect the next rating to be made available sometime around January 15, 2027.
While ratings are subjective and will change, the latest Imax (IMAX) rating was a maintained with a price target of $39.00 to $44.00. The current price Imax (IMAX) is trading at is $34.61, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.